Decoy Therapeutics
Cambridge, Massachusetts, United States · Biotechnology, Health Care, Pharmaceutical · 2 employees
Decoy Therapeutics, based in Cambridge, Massachusetts, is a pharmaceutical company focused on leveraging artificial intelligence to develop treatments for respiratory diseases. With significant backing from major investors including Johnson & Johnson and the Bill and Melinda Gates Foundation, Decoy Therapeutics is poised to advance multiple drug candidates that address significant unmet needs in n
Funding history
- Series seed — $1.2M — Jul 2025
- Series seed — $1.2M — Apr 2025
Recent signals
- Jun 01, 2026: Decoy Therapeutics Collaborates with hVIVO to Advance D-MAV Candidate into Clinical Trials.
- Jul 14, 2025: Raised $1.2M in Series seed
- Apr 28, 2025: Raised $1.2M in Series seed
See plans & pricing → Track Decoy Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.